These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35962372)

  • 1. Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning.
    Marathe G; Moodie EEM; Brouillette MJ; Cox J; Cooper C; Delaunay CL; Conway B; Hull M; Martel-Laferrière V; Vachon ML; Walmsley S; Wong A; Klein MB;
    BMC Med Res Methodol; 2022 Aug; 22(1):223. PubMed ID: 35962372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada.
    Marathe G; Moodie EEM; Brouillette MJ; Lanièce Delaunay C; Cox J; Martel-Laferrière V; Gill J; Cooper C; Pick N; Vachon ML; Walmsley S; Klein MB;
    Clin Infect Dis; 2023 Feb; 76(3):e702-e709. PubMed ID: 35789253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Food Insecurity on Depressive Symptoms Among HIV-HCV Co-infected People.
    Aibibula W; Cox J; Hamelin AM; Moodie EEM; Naimi AI; McLinden T; Klein MB; Brassard P;
    AIDS Behav; 2017 Dec; 21(12):3464-3472. PubMed ID: 29076031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between depressive symptoms, CD4 count and HIV viral suppression among HIV-HCV co-infected people.
    Aibibula W; Cox J; Hamelin AM; Moodie EEM; Anema A; Klein MB; Brassard P;
    AIDS Care; 2018 May; 30(5):643-649. PubMed ID: 29374972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food Insecurity in HIV-Hepatitis C Virus Co-infected Individuals in Canada: The Importance of Co-morbidities.
    Cox J; Hamelin AM; McLinden T; Moodie EE; Anema A; Rollet-Kurhajec KC; Paradis G; Rourke SB; Walmsley SL; Klein MB;
    AIDS Behav; 2017 Mar; 21(3):792-802. PubMed ID: 26912217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Will a quadruple multiplexed point-of-care screening strategy for HIV-related co-infections be feasible and impact detection of new co-infections in at-risk populations? Results from cross-sectional studies.
    Pai NP; Dhurat R; Potter M; Behlim T; Landry G; Vadnais C; Rodrigues C; Joseph L; Shetty A
    BMJ Open; 2014 Dec; 4(12):e005040. PubMed ID: 25510882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory.
    Golub ET; Latka M; Hagan H; Havens JR; Hudson SM; Kapadia F; Campbell JV; Garfein RS; Thomas DL; Strathdee SA;
    J Urban Health; 2004 Jun; 81(2):278-90. PubMed ID: 15136661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
    Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
    Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mediating Role of Depressive Symptoms in the Association Between Food Insecurity and HIV Related Health Outcomes Among HIV-HCV Co-Infected People.
    Aibibula W; Cox J; Hamelin AM; Klein MB; Brassard P
    AIDS Behav; 2020 Jul; 24(7):2188-2194. PubMed ID: 31950306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for hepatitis c virus co-infection among human immunodeficiency virus-infected patients and effect of hepatitis c virus infection on acquired immunodeficiency syndrome cases at baseline.
    Yakubu A; Hali B; Maiyaki AS
    Ann Afr Med; 2021; 20(4):297-301. PubMed ID: 34893569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort.
    Cox J; Maurais E; Hu L; Moodie EE; Law S; Bozinoff N; Potter M; Rollet K; Hull M; Tyndall M; Cooper C; Gill J; Saeed S; Klein MB;
    Drug Alcohol Depend; 2014 Apr; 137():121-8. PubMed ID: 24559606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
    Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
    BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C prevalence in HIV-infected individuals: a comparison of inpatient and outpatient care.
    Zhu Z; Dhir T; Soe M; Green L; Jiang N
    Int J STD AIDS; 2014 Oct; 25(11):806-11. PubMed ID: 24492852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of social factors on human immunodeficiency virus and hepatitis C virus co-infection in a minority region of Si-chuan, the People's Republic of China: a population-based survey and testing study.
    Dong C; Huang ZJ; Martin MC; Huang J; Liu H; Deng B; Lai W; Liu L; Yang Y; Hu Y; Qin G; Zhang L; Song Z; Wei D; Nan L; Wang Q; Deng H; Zhang J; Wong FY; Yang W
    PLoS One; 2014; 9(7):e101241. PubMed ID: 24988219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study.
    Ionita G; Malviya A; Rajbhandari R; Schluter WW; Sharma G; Kakchapati S; Rijal S; Dixit S
    Int J Infect Dis; 2017 Jul; 60():64-69. PubMed ID: 28483724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-based alcohol reduction intervention for alcohol-using HIV/HCV co-infected Russian women in clinical care: study protocol for a randomized controlled trial.
    DiClemente RJ; Brown JL; Capasso A; Revzina N; Sales JM; Boeva E; Gutova LV; Khalezova NB; Belyakov N; Rassokhin V
    Trials; 2021 Feb; 22(1):147. PubMed ID: 33596972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.
    Bailey H; Nizova N; Martsynovska V; Volokha A; Malyuta R; Cortina-Borja M; Thorne C;
    BMC Infect Dis; 2016 Dec; 16(1):755. PubMed ID: 27955711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic distribution and hepatic fibrosis among HIV/HCV co-infected individuals in Southern China: a retrospective cross-sectional study.
    Zhou K; Hu F; Wang C; Xu M; Lan Y; Morano JP; Lemon SM; Tucker JD; Cai W
    BMC Infect Dis; 2015 Sep; 15():401. PubMed ID: 26424404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
    Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J;
    Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.